Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain

Abstract

In order to investigate activation and internalization of c-kit we created a functional c-kit-EGFP chimera by inserting EYFP (enhanced yellow fluorescent protein) within the extracellular domain of c-kit immediately downstream of the signal sequence, SS-EYFP-kit. This location was chosen because the C-terminal fusion of EGFP to c-kit unexpectedly caused constitutive activation of the c-kit tyrosine kinase. As analysed in fixed cells and by real time imaging in vivo, SCF induced activation led to internalization of the fusion construct and translocation to punctate structures resembling vesicles. Analysis of the internalization process by time lapse imaging revealed high mobility and discontinuous movement of these vesicles and their predominantly radial tracks. Two subsets of vesicles were observed: Traffic of the majority of vesicles was directed from the periphery to the center of the cell and most likely represents the internalization of activated receptor molecules via the endosomal pathway. However, some vesicular structures were observed to move towards the periphery of the cell and probably contain newly synthesized protein to replace internalized receptor molecules. The calculated velocity of moving vesicles ranged from 0.05 to 0.2 μm per se. Vesicle formation upon SCF induced dimerization of the receptor was strictly dependent on kinase activity of c-kit. Treatment of cells with phenylarsine oxide, an agent blocking receptor internalization, prior to SCF stimulation resulted in abrogation of the translocation of the chimera to vesicles whereas accumulation of vesicles was observed when cells were treated with proteasome inhibitors. Cholesterol depletion of the cell membrane by methyl-β-cyclodextrin resulted in dose dependent reduction of receptor internalization indicating that c-kit may be present in lipid rafts or that intact lipid rafts are required for efficient internalization of the receptor. Using the induction of vesicular structures as a sign of efficient internalization of the receptor analysis of mutant c-kit constructs deficient either in activation of PI3-Kinase or Src revealed that internalization of c-kit is dependent on recruitment of Src but not PI3-Kinase.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G . 1998 J. Biol. Chem. 273: 33174–33183

  • Beslu N, LaRose J, Casteran N, Birnbaum D, Lecocq E, Dubreuil P, Rottapel R . 1996 J. Biol. Chem. 271: 20075–20081

  • Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T . 2000 Nat. Genet. 24: 157–162

  • Broudy VC . 1997 Blood 90: 1345–1364

  • Broudy VC, Lin NL, Buhring HJ, Komatsu N, Kavanagh TJ . 1998 Blood 91: 898–906

  • Broudy VC, Lin NL, Liles WC, Corey SJ, O'Laughlin B, Mou S, Linnekin D . 1999 Blood 94: 1979–1986

  • Carter RE, Sorkin A . 1998 J. Biol. Chem. 273: 35000–35007

  • Caruana G, Cambareri AC, Ashman LK . 1999 Oncogene 18: 5573–5581

  • Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N . 1997 Leukemia 11: 1404–1428

  • Coutinho S, Jahn T, Lewitzky M, Feller S, Hutzler P, Peschel C, Duyster J . 2000 Blood 96: 618–624

  • De Angelis DA, Miesenbock G, Zemelman BV, Rothman JE . 1998 Proc. Natl. Acad. Sci. USA 95: 12312–12316

  • Deberry C, Mou S, Linnekin D . 1997 Biochem. J. 327: 73–80

  • Duyster J, Baskaran R, Wang JY . 1995 Proc. Natl. Acad. Sci. USA 92: 1555–1559

  • Feng Y, Minnerly JC, Zurfluh LL, Joy WD, Hood WF, Abegg AL, Grabbe ES, Shieh JJ, Thurman TL, McKearn JP, McWherter CA . 1999 Biochemistry 38: 4553–4563

  • Fischer M, Goldschmidt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S . 1997 Nat. Biotechnol. 15: 142–145

  • Gommerman JL, Rottapel R, Berger SA . 1997 J. Biol. Chem. 272: 30519–30525

  • Gordon GW, Berry G, Liang XH, Levine B, Herman B . 1998 Biophys J. 74: 2702–2713

  • Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A . 1996 Br. J. Haematol. 94: 5–16

  • Joly M, Kazlauskas A, Corvera S . 1995 J. Biol. Chem. 270: 13225–13230

  • Kanakura Y, Furitsu T, Tsujimura T, Butterfield JH, Ashman LK, Ikeda H, Kitayama H, Kanayama Y, Matsuzawa Y, Kitamura Y . 1994 Leukemia 8: (Suppl 1) 18–S22

  • Keller P, Simons K . 1998 J. Cell. Biol. 140: 1357–1367

  • Krystal GW, DeBerry CS, Linnekin D, Litz J . 1998 Cancer Res. 58: 4660–4666

  • Kurzchalia TV, Parton RG . 1999 Curr. Opin. Cell. Biol. 11: 424–431

  • Langley KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR, Chang DG, Smith KA, Zsebo KM . 1993 Blood 81: 656–660

  • Lennartson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L . 1999 Oncogene 18: 5546–5553

  • Li Q, Kondoh G, Inafuku S, Nishimune Y, Hakura A . 1996 Cancer Res. 56: 4343–4346

  • Liu L, Cutler RL, Mui AL, Krystal G . 1994 J. Biol. Chem. 269: 16774–16779

  • Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schechter NM . 1997 Proc. Natl. Acad. Sci. USA 94: 9017–9021

  • Mahajan NP, Linder K, Berry G, Gordon GW, Heim R, Herman B . 1998 Nat. Biotechnol. 16: 547–552

  • Miyazawa K, Toyama K, Gotoh A, Hendrie PC, Mantel C, Broxmeyer HE . 1994 Blood 83: 137–145

  • Moran M, Miceli MC . 1998 Immunity 9: 787–796

  • Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, Gunthert U, Huber LA . 1999 J. Cell. Biol. 146: 843–854

  • Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P . 1995 EMBO J. 14: 473–483

  • Shimizu Y, Ashman LK, Du Z, Schwartz LB . 1996 J. Immunol. 156: 3443–3449

  • Simons K, Ikonen E . 1997 Nature 387: 569–572

  • Thommes K, Lennartsson J, Carlberg M, Ronnstrand L . 1999 Biochem. J. 341: 211–216

  • Timokhina I, Kissel H, Stella G, Besmer P . 1998 EMBO J. 17: 6250–6262

  • Wakioka T, Sasaki A, Mitsui K, Yokouchi M, Inoue A, Komiya S, Yoshimura A . 1999 Leukemia 13: 760–767

  • Wu H, Klingmuller U, Besmer P, Lodish HF . 1995 Nature 377: 242–246

  • Yee NS, Hsiau CW, Serve H, Vosseller K, Besmer P . 1994 J. Biol. Chem. 269: 31991–31998

Download references

Acknowledgements

This work was supported by a grant to J Duyster from the José-Carreras Stiftung and Mildren-Scheel Siftung and by SFB grant No 456 to J Duyster and C Peschel. T Jahn and C Miething are supported by a fellowship from the Deutsche José-Carreras Stiftung. We thank Kenneth I Weinberg, Children's Hospital Los Angeles, for very helpful suggestions and comments and critically reading the manuscript. We thank Dr Christian Heinemann, TILL Photonics, for friendly and skilful support. We thank Claudia Mugler for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Justus Duyster.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jahn, T., Seipel, P., Coutinho, S. et al. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain. Oncogene 21, 4508–4520 (2002). https://doi.org/10.1038/sj.onc.1205559

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205559

Keywords

This article is cited by

Search

Quick links